+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
540359 PARMAX

Parmax Pharma Share Price

 
Stock touched all time high

 

Parmax Pharma live price: ₹82.88. It opened at ₹83 vs previous close ₹81; intraday high/low: ₹83/₹83. The 50 & 200 DMA stand at ₹53.55/₹40.08.

Parmax Pharma Performance

  • Today's Low
  • ₹83
  • Today's High
  • ₹83
  • 52 Week Low
  • ₹23
  • 52 Week High
  • ₹83
  • Open Price₹83
  • Previous Close₹81
  • Volume2,056
  • 50 DMA₹53.55
  • 100 DMA₹44.77
  • 200 DMA₹40.08

Parmax Pharma Chart

Investment Returns

  • Over 1 Month + 103.79%
  • Over 3 Month + 165.81%
  • Over 6 Month + 146.23%
  • Over 1 Year + 118.97%

Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!

Invest Now

Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -7.5
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 31
  • P/B Ratio
  • -4.5
  • Average True Range
  • 2.34
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 9.46
  • RSI
  • 90.83
  • MFI
  • 100

Parmax Pharma Financials

Parmax Pharma Technicals

EMA & SMA

Current Price
₹82.88
+ 1.62 (1.99%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹67.80
  • 50 Day
  • ₹53.60
  • 100 Day
  • ₹44.80
  • 200 Day
  • ₹40.10

Resistance and Support

82.88 Pivot Speed
  • R3 82.88
  • R2 82.88
  • R1 82.88
  • S1 82.88
  • S2 82.88
  • S3 82.88

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma has an operating revenue of Rs. 12.11 Cr. on a trailing 12-month basis. An annual revenue de-growth of -57% needs improvement, Pre-tax margin of -48% needs improvement, NULL It has recently broken out of a base in its weekly chart and is trading around 93% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Parmax Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-06-08 Fund raising
2026-06-02 Audited Results (Revised)
2026-02-14 Quarterly Results
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results

Parmax Pharma Shareholding Pattern

30.8%
63.11%
6.09%

Parmax Pharma FAQs

Parmax Pharma share price is ₹82 As on 04 July, 2026 | 04:49

The Market Cap of Parmax Pharma is ₹31 Cr As on 04 July, 2026 | 04:49

The P/E ratio of Parmax Pharma is -7.5 As on 04 July, 2026 | 04:49

The PB ratio of Parmax Pharma is -4.5 As on 04 July, 2026 | 04:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23